Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,537 | -6,468 | -1,100,642 | -1,044,316 | -894,040 |
| Depreciation Amortization | 127,442 | 61,742 | 214,524 | 291,040 | 85,888 |
| Income taxes - deferred | -45,489 | 2,571 | -17,887 | -53,762 | 8,789 |
| Accounts receivable | -24,175 | -7,796 | 122,363 | 111,500 | 21,891 |
| Accounts payable and accrued liabilities | 6,772 | 8,775 | 6,478 | -10,680 | -4,739 |
| Other Working Capital | -17,581 | -58,923 | 65,943 | -144,045 | -40,191 |
| Other Operating Activity | -27,515 | -49,978 | 607,431 | 680,287 | 824,946 |
| Operating Cash Flow | $-76,083 | $-50,077 | $-101,790 | $-169,976 | $2,544 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 22,486 | 54,769 | -112,988 | -124,454 | -68,412 |
| Net Acquisitions | N/A | N/A | 324,260 | N/A | N/A |
| Purchase Sale Intangibles | -1,906 | -844 | -10,369 | -14,217 | -3,877 |
| Other Investing Activity | 194 | -844 | -66,849 | -16,127 | -32,705 |
| Investing Cash Flow | $22,680 | $53,925 | $144,423 | $-140,581 | $-101,117 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 548,600 | 269,100 | 2,914,784 | N/A | 1,630,184 |
| Debt Issued | 1,237,315 | N/A | N/A | 2,442,484 | 0 |
| Debt Repayment | -1,237,315 | N/A | N/A | -2,171,784 | N/A |
| Common Stock Repurchased | 0 | 0 | -10,179 | -6,656 | -6,656 |
| Other Financing Activity | -769,494 | -218,016 | -2,716,527 | 41,530 | -1,499,051 |
| Financing Cash Flow | $-220,894 | $51,084 | $188,078 | $305,574 | $124,477 |
| Exchange Rate Effect | -41 | -41 | 1,896 | 1,767 | 1,801 |
| Beginning Cash Position | 281,989 | 281,989 | 49,382 | 49,382 | 49,382 |
| End Cash Position | 7,651 | 336,880 | 281,989 | 46,166 | 77,087 |
| Net Cash Flow | $-274,338 | $54,891 | $232,607 | $-3,216 | $27,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,083 | -50,077 | -101,790 | -169,976 | 2,544 |
| Capital Expenditure | -89,232 | -41,646 | -190,956 | -177,823 | -103,416 |
| Free Cash Flow | -165,315 | -91,723 | -292,746 | -347,799 | -100,872 |